We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-14.49%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$183B
AUM Growth
-$41.5B
Cap. Flow
-$8B
Cap. Flow %
-4.38%
Top 10 Hldgs %
23.66%
Holding
10,385
New
1,237
Increased
3,761
Reduced
3,800
Closed
1,371

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$783M
2
MS icon
Morgan Stanley
MS
+$518M
3
LOW icon
Lowe's Companies
LOW
+$474M
4
V icon
Visa
V
+$425M
5
NFLX icon
Netflix
NFLX
+$419M

Sector Composition

Rank Sector Weight
1 Financials 5.01%
2 Technology 4.76%
3 Consumer Discretionary 3.82%
4 Industrials 3.81%
5 Communication Services 3.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRTX
8551
CALL
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$22K ﹤0.01%
60
+7
+13% +$2.75K
EMAN
8552
DELISTED
eMagin Corporation
EMAN
$22K ﹤0.01%
+21,682
New +$28.2K
VIVE
8553
DELISTED
VIVEVE MED INC
VIVE
$22K ﹤0.01%
+21
New +$50.4K
MN
8554
DELISTED
MANNING & NAPIER, INC.
MN
$22K ﹤0.01%
+12,336
New +$25.6K
NBRV
8555
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$22K ﹤0.01%
61
-96
-61% -$51.6K
SMRT
8556
CALL
DELISTED
Stein Mart Inc
SMRT
$22K ﹤0.01%
20,500
-10,100
-33% -$17.4K
PIR
8557
DELISTED
Pier 1 Imports, Inc.
PIR
$22K ﹤0.01%
3,647
-20,747
-85% -$568K
SDLP
8558
PUT
DELISTED
SEADRILL PARTNERS LLC
SDLP
$22K ﹤0.01%
+1,260
New +$37K
ONCS
8559
DELISTED
OncoSec Medical Incorporated
ONCS
$22K ﹤0.01%
+155
New +$38.9K
CYTR
8560
CALL
DELISTED
CytRx Corp
CYTR
$22K ﹤0.01%
48,900
-15,000
-23% -$10.4K
PGLC
8561
CALL
DELISTED
Pershing Gold Corporation. Common Stock
PGLC
$22K ﹤0.01%
+20,500
New +$24.5K
AST
8562
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$22K ﹤0.01%
35,597
-33,120
-48% -$34.4K
ALTO icon
8563
CALL
Alto Ingredients
ALTO
$324M
$21K ﹤0.01%
24,200
-9,800
-29% -$16.2K
AVXL icon
8564
CALL
Anavex Life Sciences
AVXL
$298M
$21K ﹤0.01%
13,700
-2,400
-15% -$5.45K
DRRX
8565
DELISTED
DURECT Corp
DRRX
$21K ﹤0.01%
4,265
-3,024
-41% -$26.4K
DXF
8566
Eason Technology Ltd
DXF
$1.64M
$21K ﹤0.01%
+9
New +$39K
FTEK icon
8567
Fuel Tech
FTEK
$45.3M
$21K ﹤0.01%
+18,021
New +$22.7K
NDRA icon
8568
ENDRA Life Sciences
NDRA
$5.68M
0
NMM icon
8569
CALL
Navios Maritime Partners
NMM
$2.33B
$21K ﹤0.01%
1,640
-387
-19% -$7.93K
SLS icon
8570
SELLAS Life Sciences
SLS
$2.58B
$21K ﹤0.01%
+340
New +$26.3K
SMMT icon
8571
Summit Therapeutics
SMMT
$10.6B
$21K ﹤0.01%
+18,001
New +$28K
VIVO
8572
VivoPower PLC
VIVO
$150M
$21K ﹤0.01%
+3,530
New +$40.9K
HURA
8573
TuHURA Biosciences
HURA
$157M
$21K ﹤0.01%
3
+1
+50% +$9.7K
BYU
8574
DELISTED
BAIYU Holdings, Inc. Common Stock
BYU
$21K ﹤0.01%
52
+23
+79% +$14.6K
SCU
8575
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$21K ﹤0.01%
2,242
-2,751
-55% -$33.5K

Similar funds

Citadel Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Citadel Advisors held 10,385 positions worth $183B, down 19% from $224B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Citadel Advisors withdrew a net $8B in Q4 2018, closing 1,371 positions and reducing 3,800 holdings. Its most notable exit was Aetna Inc, an estimated $783M position sold in full.

By sector, the portfolio is most concentrated in Financials at 5% of assets, down from 5.9% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in Assurant worth $99.4M.

  • Citadel Advisors's largest Q4 2018 buy was Assurant: 1,111,342 shares worth $99.4M.
  • Citadel Advisors added most to Amazon in Q4 2018, an estimated $1.68B increase.
  • Citadel Advisors's biggest Q4 2018 reduction was Morgan Stanley, cutting an estimated $518M.
  • Citadel Advisors fully exited Aetna Inc in Q4 2018, selling an estimated $783M.
  • Citadel Advisors's ten largest holdings make up 24% of its $183B portfolio in Q4 2018.
  • Citadel Advisors opened 1,237 new positions and closed 1,371 in Q4 2018.
  • Citadel Advisors's portfolio value fell 19% quarter-over-quarter to $183B.

Based on Citadel Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.